M. Porta et al., Validity of the hospital discharge diagnosis in epidemiologic studies of biliopancreatic pathology, EUR J EPID, 16(6), 2000, pp. 533-541
Citations number
42
Categorie Soggetti
Envirnomentale Medicine & Public Health","Medical Research General Topics
Background: The aim was to analyse the magnitude, direction and predictors
of change in the main hospital discharge diagnosis (HDD) after a clinical e
xpert review, among patients included in a multicentre molecular epidemiolo
gic study of biliopancreatic diseases. Methods: A total of 602 patients wit
h a suspicion diagnosis of pancreas cancer (PC), cancer of the extrahepatic
biliary system (CEBS) or benign biliopancreatic pathologies (BPP) were pro
spectively recruited at five general hospitals. A structured form was used
to collect information from medical records. A panel of experts revised all
diagnostic information and established the main clinico-pathological diagn
osis (CPD) by consensus. Results: Of the 204 cases with a HDD of PC, 176 (8
6%) were deemed to have a CPD of PC, eight of CEBS, twelve a neoplasm of di
fferent origin, four BPP and four syndromic diagnoses. Thus, 28 cases (14%)
were false positives. Of the 129 patients with a HDD of CEBS, 15 (12%) wer
e false positives. Nine of the 396 cases with a HDD of non-PC (2%) had a CP
D of PC (false negatives), whilst 14 of 471 patients with a HDD of non-CEBS
(3%) were deemed to have CEBS. Overall, sensitivity and specificity of HDD
for PC were, respectively, 95 and 93%, and for CEBS, 89 and 97%. Cytohisto
logical confirmation and laparotomy were independent predictors of diagnost
ic change. Conclusions: Validity of the HDD was high, but its association w
ith some clinical variables suggests that sole reliance on HDD can signific
antly bias results, and highlights the need to review all HDDs. Alternative
ly, only patients at high risk of misdiagnosis could be reviewed: primarily
, those lacking a cytohistological diagnosis or a laparotomy. No exclusions
appear warranted solely on the basis of age, gender or tumour spread.